“Salidroside exerts anti-tumor effects in ovarian cancer by inhibiting STAT3/c-Myc pathway-mediated glycolysis” (2024) Biomolecules and Biomedicine, 25(1), pp. 82–93. doi:10.17305/bb.2024.10867.